{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:51:24Z","timestamp":1787316684782,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,9]],"date-time":"2014-02-09T00:00:00Z","timestamp":1391904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11882-014-0423-y","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T01:31:52Z","timestamp":1391823112000},"source":"Crossref","is-referenced-by-count":73,"title":["Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases"],"prefix":"10.1007","volume":"14","author":[{"given":"Anja","family":"Rabenhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,9]]},"reference":[{"issue":"7","key":"423_CR1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","volume":"5","author":"SR Dillon","year":"2004","unstructured":"Dillon SR et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752\u201360.","journal-title":"Nat Immunol"},{"issue":"6-7","key":"423_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejcb.2011.07.006","volume":"91","author":"C Cornelissen","year":"2012","unstructured":"Cornelissen C et al. Signaling by IL-31 and functional consequences. Eur J Cell Biol. 2012;91(6-7):552\u201366. This review provides an excellent summary of IL-31 structure and function.","journal-title":"Eur J Cell Biol"},{"key":"423_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0083-6729(06)74008-0","volume":"74","author":"Q Chen","year":"2006","unstructured":"Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm. 2006;74:207\u201328.","journal-title":"Vitam Horm"},{"issue":"5\u20136","key":"423_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","volume":"19","author":"Q Zhang","year":"2008","unstructured":"Zhang Q et al. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev. 2008;19(5\u20136):347\u201356.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"33","key":"423_CR5","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.3748\/wjg.14.5154","volume":"14","author":"A Andoh","year":"2008","unstructured":"Andoh A et al. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 2008;14(33):5154\u201361.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"423_CR6","first-page":"941","volume":"19","author":"Y Yagi","year":"2007","unstructured":"Yagi Y et al. Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int J Mol Med. 2007;19(6):941\u20136.","journal-title":"Int J Mol Med"},{"key":"423_CR7","doi-asserted-by":"crossref","unstructured":"Baumann, R., et al., The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin Transl Allergy, 2012. 2(1): p. 2045-7022. This paper shows that IL-31 is not only important in the skin; after nasal challenge it is released into nasal secretions in patients with allergic rhinitis","DOI":"10.1186\/2045-7022-2-13"},{"issue":"2","key":"423_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","volume":"117","author":"E Sonkoly","year":"2006","unstructured":"Sonkoly E et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117(2):411\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"423_CR9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2007.07.065","volume":"120","author":"F Schulz","year":"2007","unstructured":"Schulz F et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol. 2007;120(5):1097\u2013102.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"423_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2340\/00015555-0958","volume":"90","author":"N Nagy","year":"2010","unstructured":"Nagy N et al. Common IL-31 gene haplotype associated with non-atopic eczema is not implicated in epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2010;90(6):631\u20132.","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"423_CR11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-0625.2011.01374.x","volume":"20","author":"C-CE Lan","year":"2011","unstructured":"Lan C-CE et al. Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol. 2011;20(12):975\u20139.","journal-title":"Exp Dermatol"},{"issue":"2","key":"423_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4132\/KoreanJPathol.2012.46.2.162","volume":"46","author":"JI Yu","year":"2012","unstructured":"Yu JI et al. Identifying Polymorphisms in IL-31 and Their Association with Susceptibility to Asthma. Korean J Pathol. 2012;46(2):162\u20138.","journal-title":"Korean J Pathol"},{"issue":"5","key":"423_CR13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1468-3083.2012.04649.x","volume":"27","author":"M Sokolowska-Wojdylo","year":"2013","unstructured":"Sokolowska-Wojdylo M et al. Association of distinct IL-31 polymorphisms with pruritus and severity of atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27(5):662\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"423_CR14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaci.2005.10.046","volume":"117","author":"J Bilsborough","year":"2006","unstructured":"Bilsborough J et al. IL-31 is associated with cutaneous lymphocyte antigen\u2013positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2006;117(2):418\u201325.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"423_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/intimm\/dxq027","volume":"22","author":"PF Cheung","year":"2010","unstructured":"Cheung PF et al. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol. 2010;22(6):453\u201367.","journal-title":"Int Immunol"},{"issue":"1","key":"423_CR16","first-page":"17","volume":"7","author":"CK Wong","year":"2012","unstructured":"Wong CK et al. Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PLoS ONE. 2012;7(1):17.","journal-title":"PLoS ONE"},{"issue":"5","key":"423_CR17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2133.2011.10487.x","volume":"165","author":"C Cornelissen","year":"2011","unstructured":"Cornelissen C et al. Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells. Br J Dermatol. 2011;165(5):966\u201375.","journal-title":"Br J Dermatol"},{"issue":"7","key":"423_CR18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1398-9995.2011.02545.x","volume":"66","author":"S Kasraie","year":"2011","unstructured":"Kasraie S et al. Functional effects of interleukin 31 in human primary keratinocytes. Allergy. 2011;66(7):845\u201352.","journal-title":"Allergy"},{"issue":"2","key":"423_CR19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jaci.2013.03.050","volume":"132","author":"B Stott","year":"2013","unstructured":"Stott B et al. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol. 2013;132(2):446\u201354.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"423_CR20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1398-9995.2009.02255.x","volume":"65","author":"S Kasraie","year":"2010","unstructured":"Kasraie S, Niebuhr M, Werfel T. Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins. Allergy. 2010;65(6):712\u201321.","journal-title":"Allergy"},{"issue":"6","key":"423_CR21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/all.12152","volume":"68","author":"S Kasraie","year":"2013","unstructured":"Kasraie S, Niebuhr M, Werfel T. Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1\/2 and down-regulates IL-12p40 production in activated human macrophages. Allergy. 2013;68(6):739\u201347.","journal-title":"Allergy"},{"issue":"23","key":"423_CR22","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1182\/blood-2008-09-179416","volume":"113","author":"T Ishii","year":"2009","unstructured":"Ishii T et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood. 2009;113(23):5942\u201350.","journal-title":"Blood"},{"issue":"7","key":"423_CR23","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","volume":"184","author":"F Niyonsaba","year":"2010","unstructured":"Niyonsaba F et al. Antimicrobial Peptides Human \u03b2-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells. J Immunol. 2010;184(7):3526\u201334.","journal-title":"J Immunol"},{"issue":"3","key":"423_CR24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","volume":"124","author":"L Escribano","year":"2009","unstructured":"Escribano L et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol. 2009;124(3):514\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"423_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-012-0322-z","volume":"13","author":"M Frieri","year":"2013","unstructured":"Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013;13(1):27\u201332.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"423_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/ped.2013.0275","volume":"26","author":"M Frieri","year":"2013","unstructured":"Frieri M, Quershi M. Pediatric Mastocytosis: A Review of the Literature. Pediatr Allergy Immunol Pulmonol. 2013;26(4):175\u201380.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"423_CR27","doi-asserted-by":"crossref","unstructured":"Hartmann, K., et al., Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. J Allergy Clin Immunol, 2013. 132(1): p. 232-235.e4. This study is the first to describe altered serum levels of IL-31 in patients with mastocytosis.","DOI":"10.1016\/j.jaci.2012.11.008"},{"key":"423_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000323307","volume":"41","author":"CH Lee","year":"2011","unstructured":"Lee CH, Yu HS. Biomarkers for itch and disease severity in atopic dermatitis. Curr Probl Dermatol. 2011;41:136\u201348.","journal-title":"Curr Probl Dermatol"},{"issue":"4","key":"423_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2006.07.015","volume":"118","author":"MM Neis","year":"2006","unstructured":"Neis MM et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 2006;118(4):930\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"423_CR30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","volume":"122","author":"U Raap","year":"2008","unstructured":"Raap U et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol. 2008;122(2):421\u20133.","journal-title":"J Allergy Clin Immunol"},{"key":"423_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2249.2008.03718.x","volume":"1","author":"C Incorvaia","year":"2008","unstructured":"Incorvaia C et al. Allergy and the skin. Clin Exp Immunol. 2008;1:27\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"423_CR32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5021\/ad.2011.23.4.468","volume":"23","author":"S Kim","year":"2011","unstructured":"Kim S et al. IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis. Ann Dermatol. 2011;23(4):468\u201373.","journal-title":"Ann Dermatol"},{"issue":"4","key":"423_CR33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000323905","volume":"156","author":"M Niebuhr","year":"2011","unstructured":"Niebuhr M et al. Staphylococcal alpha-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol. 2011;156(4):412\u20135.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"423_CR34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1468-3083.2010.03794.x","volume":"25","author":"MH Ezzat","year":"2011","unstructured":"Ezzat MH, Hasan ZE, Shaheen KY. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol. 2011;25(3):334\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"423_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-1191","volume":"92","author":"S Nobbe","year":"2012","unstructured":"Nobbe S et al. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol. 2012;92(1):24\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"423_CR36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0625.2012.01487.x","volume":"21","author":"K Szegedi","year":"2012","unstructured":"Szegedi K et al. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol. 2012;21(6):431\u20136.","journal-title":"Exp Dermatol"},{"key":"423_CR37","doi-asserted-by":"crossref","unstructured":"Hawro, T., et al., Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy, 2013. 20(10): p. 12316. This article nicely shows that IL-31 does not induce an immediate itch response in humans.","DOI":"10.1111\/all.12316"},{"key":"423_CR38","doi-asserted-by":"crossref","unstructured":"Ohmatsu, H., et al., Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma. Acta Derm Venereol, 2012. 92(3): p. 282-3. An excellent study providing new insights into the role of IL-31 in cutaneous T-cell lymphoma.","DOI":"10.2340\/00015555-1345"},{"issue":"2","key":"423_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2005.04.040","volume":"516","author":"A Takaoka","year":"2005","unstructured":"Takaoka A et al. Expression of IL-31 gene transcripts in NC\/Nga mice with atopic dermatitis. Eur J Pharmacol. 2005;516(2):180\u20131.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"423_CR40","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/jid.2013.227","volume":"133","author":"EM Singer","year":"2013","unstructured":"Singer EM et al. IL-31 Is Produced by the Malignant T-Cell Population in Cutaneous T-Cell Lymphoma and Correlates with CTCL Pruritus. J Invest Dermatol. 2013;133(12):2783\u20135.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"423_CR41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0625.2010.01067.x","volume":"19","author":"U Raap","year":"2010","unstructured":"Raap U et al. Increased levels of serum IL-31 in chronic spontaneous urticaria. Exp Dermatol. 2010;19(5):464\u20136.","journal-title":"Exp Dermatol"},{"issue":"3","key":"423_CR42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-012-1293-6","volume":"305","author":"J Narbutt","year":"2013","unstructured":"Narbutt J et al. Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res. 2013;305(3):191\u20135.","journal-title":"Arch Dermatol Res"},{"key":"423_CR43","first-page":"1","volume":"7","author":"M Zhang","year":"2013","unstructured":"Zhang M et al. Serum levels of cytokines in systemic lupus erythematosus : Association study in a Chinese population. Z Rheumatol. 2013;7:1\u20134.","journal-title":"Z Rheumatol"},{"issue":"1","key":"423_CR44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1684\/ejd.2010.1196","volume":"21","author":"K Park","year":"2011","unstructured":"Park K et al. Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo. Eur J Dermatol. 2011;21(1):135\u20136.","journal-title":"Eur J Dermatol"},{"issue":"5","key":"423_CR45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/jid.2012.484","volume":"133","author":"YM Shiao","year":"2013","unstructured":"Shiao YM et al. MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis. J Invest Dermatol. 2013;133(5):1375\u20138.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"423_CR46","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2011.10.042","volume":"129","author":"C Cornelissen","year":"2012","unstructured":"Cornelissen C et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol. 2012;129(2):426\u201333.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"423_CR47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2008.00766.x","volume":"18","author":"\u00d8 Grimstad","year":"2009","unstructured":"Grimstad \u00d8 et al. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC\/Nga mice: a model of atopic dermatitis. Exp Dermatol. 2009;18(1):35\u201343.","journal-title":"Exp Dermatol"},{"issue":"3\u20134","key":"423_CR48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000346609","volume":"91","author":"SA Shah","year":"2013","unstructured":"Shah SA et al. Effects of interleukin-31 on MUC5AC gene expression in nasal allergic inflammation. Pharmacology. 2013;91(3\u20134):158\u201364.","journal-title":"Pharmacology"},{"issue":"1","key":"423_CR49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2010.09.029","volume":"127","author":"M Okano","year":"2011","unstructured":"Okano M et al. Characterization of pollen antigen-induced IL-31 production by PBMCs in patients with allergic rhinitis. J Allergy Clin Immunol. 2011;127(1):277\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"423_CR50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1398-9995.2007.01566.x","volume":"63","author":"Z Lei","year":"2008","unstructured":"Lei Z et al. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy. 2008;63(3):327\u201332.","journal-title":"Allergy"},{"issue":"4","key":"423_CR51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2567.2007.02668.x","volume":"122","author":"WK Ip","year":"2007","unstructured":"Ip WK et al. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology. 2007;122(4):532\u201341.","journal-title":"Immunology"},{"issue":"14","key":"423_CR52","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483\u201394.","journal-title":"N Engl J Med"},{"key":"423_CR53","doi-asserted-by":"crossref","unstructured":"Arai, I., et al., A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice. Exp Dermatol, 2013. 22(10): p. 669-71. Interesting murine study about IL-31-induced itch-associated scratching behavior.","DOI":"10.1111\/exd.12222"},{"issue":"1","key":"423_CR54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-3164.2012.01098.x","volume":"24","author":"AJ Gonzales","year":"2013","unstructured":"Gonzales AJ et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48\u201353.","journal-title":"Vet Dermatol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-014-0423-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-014-0423-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T02:24:53Z","timestamp":1597458293000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-014-0423-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,9]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1007\/s11882-014-0423-y","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,9]]},"article-number":"423"}}